IRONWOOD PHARMACEUTICALS INC's ticker is IRWD and the CUSIP is 46333X108. A total of 222 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,829,718 | +2.4% | 189,999 | +13.2% | 0.00% | 0.0% |
| Q2 2023 | $1,786,028 | -5.3% | 167,856 | -6.4% | 0.00% | -25.0% |
| Q1 2023 | $1,886,326 | -10.6% | 179,318 | +5.3% | 0.00% | -20.0% |
| Q4 2022 | $2,109,257 | +33.7% | 170,236 | +11.8% | 0.01% | +25.0% |
| Q3 2022 | $1,578,000 | +310.9% | 152,318 | +419.4% | 0.00% | +300.0% |
| Q2 2022 | $384,000 | -5.0% | 29,326 | +1.1% | 0.00% | 0.0% |
| Q1 2022 | $404,000 | +7.7% | 29,003 | +1.9% | 0.00% | 0.0% |
| Q4 2021 | $375,000 | -78.5% | 28,474 | -78.3% | 0.00% | -75.0% |
| Q3 2021 | $1,742,000 | +295.9% | 131,007 | +298.7% | 0.00% | +300.0% |
| Q2 2021 | $440,000 | -83.0% | 32,857 | -85.7% | 0.00% | -85.7% |
| Q4 2020 | $2,593,000 | +32.8% | 230,146 | +4.2% | 0.01% | +16.7% |
| Q3 2020 | $1,952,000 | +76.0% | 220,840 | +102.9% | 0.01% | +100.0% |
| Q2 2020 | $1,109,000 | +29.7% | 108,825 | +28.3% | 0.00% | 0.0% |
| Q1 2020 | $855,000 | -26.5% | 84,789 | -2.9% | 0.00% | 0.0% |
| Q4 2019 | $1,163,000 | +116.2% | 87,359 | +39.5% | 0.00% | +200.0% |
| Q3 2019 | $538,000 | -20.4% | 62,631 | +1.4% | 0.00% | -50.0% |
| Q2 2019 | $676,000 | +1026.7% | 61,774 | +1856.7% | 0.00% | – |
| Q2 2018 | $60,000 | +25.0% | 3,157 | +1.5% | 0.00% | – |
| Q1 2018 | $48,000 | -98.7% | 3,110 | -98.7% | 0.00% | -100.0% |
| Q4 2017 | $3,673,000 | -7.7% | 245,031 | -2.9% | 0.01% | -7.1% |
| Q3 2017 | $3,980,000 | -5.8% | 252,338 | +12.7% | 0.01% | -17.6% |
| Q2 2017 | $4,226,000 | +23.1% | 223,825 | +11.2% | 0.02% | +13.3% |
| Q1 2017 | $3,433,000 | +33.2% | 201,226 | +19.3% | 0.02% | +25.0% |
| Q4 2016 | $2,578,000 | +257700.0% | 168,608 | +276306.6% | 0.01% | – |
| Q3 2016 | $1,000 | 0.0% | 61 | 0.0% | 0.00% | – |
| Q2 2016 | $1,000 | 0.0% | 61 | 0.0% | 0.00% | – |
| Q1 2016 | $1,000 | -99.8% | 61 | -99.9% | 0.00% | -100.0% |
| Q3 2015 | $550,000 | – | 52,761 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 16,390,000 | $172,422,800 | 22.05% |
| 13D Management LLC | 533,562 | $5,613,073 | 2.85% |
| Quantedge Capital Pte Ltd | 541,200 | $5,693,424 | 2.22% |
| Price Jennifer C. | 520,000 | $5,470,400 | 1.74% |
| Tamarack Advisers, LP | 210,000 | $2,209,200 | 0.81% |
| Intrinsic Value Partners, LLC | 51,605 | $542,885 | 0.73% |
| Brown Capital Management | 3,933,933 | $41,384,975 | 0.62% |
| Old West Investment Management, LLC | 75,219 | $791,303 | 0.43% |
| EMC Capital Management | 43,315 | $456 | 0.38% |
| Hillsdale Investment Management Inc. | 420,617 | $4,424,891 | 0.38% |